Vaxxinova continues to grow globally

Nijmegen, NL, March 6, 2026 – In a recent article by S&P Global Animal Health, we share updates on our long-term growth strategy.
A clear commitment to being closer to our customers and providing a broad portfolio of licensed and autogenous vaccines for poultry, aqua and livestock worldwide.

Read the full post here: Vaxxinova to make more appointments to support expansion strategy